Eriny Abd-Elmaseh, M. Samy, Mohamed Abdelkader, Mostafa Fouad
{"title":"A review of phytoconstituents and biological activities of genus Phalaris","authors":"Eriny Abd-Elmaseh, M. Samy, Mohamed Abdelkader, Mostafa Fouad","doi":"10.21608/jabps.2024.263056.1212","DOIUrl":"https://doi.org/10.21608/jabps.2024.263056.1212","url":null,"abstract":"Phalaris is a genus in the family Poaceae, which contains around 21 species. The members of this genus are used in traditional folk medicine in the treatment of hypertension, diabetes mellitus, and obesity. The review aims to collect the previous phytochemistry and biological activities of the extracts. The data of the literature collected revealed the presence of different chemical classes such as flavonoids, phenolic acids, anthocyanins, alkaloids, diterpenes, fatty acids, and sterols that contribute to antioxidant, anti-diabetic, anti-hypertensive","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":" 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140391429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mahmoud A. Hashem, Amal K. Hussein, Hamdy Abdelkader, Mohammed S. Saddik
{"title":"Solubility enhancement of simvastatin for wound dressing preparation.","authors":"Mahmoud A. Hashem, Amal K. Hussein, Hamdy Abdelkader, Mohammed S. Saddik","doi":"10.21608/jabps.2024.254472.1211","DOIUrl":"https://doi.org/10.21608/jabps.2024.254472.1211","url":null,"abstract":"Simvastatin (SMV) is a well-known antihyperlipidemic drug that has demonstrated wound healing effects. However, its clinical application is hindered by poor solubility. Therefore, the objective of this study was to enhance the solubility of simvastatin by utilizing various concentrations of solvents and co-solvents for formulation in selected topical dosage forms. Mixed-solvent systems, namely Buffer-methanol, Buffer-ethanol, and Buffer-dmso, were employed. Additionally, the impact of different polymer concentrations, including carboxymethyl cellulose (CMC), hydroxypropylmethyl cellulose (HPMC), and chitosan (CHT), on drug solubility was investigated. The solubility profile of SMV in 2% w/v polymeric solutions (CMC, HPMC, and CHT) was found to be 73.5, 62.1, and 59.6 µg/mL, respectively. Notably, the use of a 2% w/v chitosan solution resulted in a remarkable 50-fold increase (73.5 µg/mL) in SMV dissolution compared to its aqueous solubility (1.45 µg/mL). This significant enhancement allows for the incorporation of large amounts of the drug in formulations. Our findings indicate that the Chitosan system with ethanol exhibited the highest solubilization effect and demonstrated the necessary characteristics for the preparation and handling of wound dressing films. This suggests a promising approach for the development of topical formulations with improved solubility and potential therapeutic benefits of simvastatin.","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":" 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140392592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Binding of curcumin near the GBT440 binding site at the alpha cleft in the sickle cell hemoglobin model [Pdb ID: 1NEJ]","authors":"Roohallah Yousefi","doi":"10.21608/jabps.2024.247027.1209","DOIUrl":"https://doi.org/10.21608/jabps.2024.247027.1209","url":null,"abstract":"Introduction: In sickle cell anemia, deoxygenated HbS molecules polymerize into long fibers in deep tissues during hypoxia, leading to erythrocyte sickling and capillary and vessel blockage. We are searching for new ligands, such as gbt440, that can inhibit HbS polymerization. Methods and Materials: We obtained the molecular model of hemoglobin [PDB ID: 1NEJ] from the Protein Data Bank and the molecular models of GBT440 and curcumin from the PubChem database. The physicochemical properties were investigated using SwissADME software, followed by docking to identify protein-ligand binding sites and determine their affinity. Finally, molecular dynamics simulations were conducted to assess the stability of the protein-ligand complex in the alpha-cleft of the hemoglobin tetramer model [PDB ID: 1NEJ]. Results and Discussion: The docking results revealed that curcumin exhibited a higher binding affinity than GBT440 to the nearby binding site of gbt440 in the alpha-cleft of the hemoglobin model. The hydrogen bonding and electrostatic interactions of the 1NEJ-GBT440 complex differed from those of the 1NEJ-curcumin complex. The results of the molecular dynamics simulation showed no significant difference in the flexibility of hemoglobin among the different ligand-hemoglobin complexes. Conclusion: The binding of curcumin to hemoglobin in the alpha cleft may inhibit the transition of hemoglobin to the tense state and stabilize the hemoglobin tetramer model [PDB ID: 1NEJ] in the R2 state. However, further investigation in the laboratory is necessary to confirm this","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":" 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140392848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Eco-friendly micellar ultra-performance liquid chromatography (UPLC) method for simultaneous determination of non-communicable diseases drugs in bulk powder, spiked human plasma and in individual dosage forms","authors":"Manal Fouad, Noha Rashed, Asmaa Hosameldin","doi":"10.21608/jabps.2023.248654.1210","DOIUrl":"https://doi.org/10.21608/jabps.2023.248654.1210","url":null,"abstract":"Green, simple and accurate micellar UPLC method was established and validated for quantitative determination of glimepiride, pioglitazone HCl, Valsartan and atorvastatin calcium trihydrate in bulk powder, tablets and spiked human plasma. Gradient separation was achieved on Kinetex 1.7µ C 18 100A (2.1-mm × 50-mm) at ambient temperature using ecofriendly gradient mobile phase composed of a mixture of 0.05 M potassium dihydrogen phosphate buffer pH 5.00 (A) with 0.10M sodium dodecyl sulfate and isopropanol (15.00-25.00%) (B) at flow rate of 0.20 mL/minute and UV detection at 230.00 nm using metformin as internal standard. The method was linear in the range of 0.50–25.00 μg/mL. The proposed method was effectively applied for the determination of glimepiride, pioglitazone HCl, valsartan and atorvastatin in bulk powder, pharmaceutical dosage forms and human plasma with good accuracy and precision. The results were compared with those of the reported methods and were found to be in good agreement. The proposed method was validated according to ICH guidelines.","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"5 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140393111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asmaa Bayoumi, Esraa Khalifa, Mohamed Sayed-Ahmed, Marwa Sharaky, M. Nazmy
{"title":"Resveratrol inhibits epithelial-mesenchymal transition in hepatocellular carcinoma","authors":"Asmaa Bayoumi, Esraa Khalifa, Mohamed Sayed-Ahmed, Marwa Sharaky, M. Nazmy","doi":"10.21608/jabps.2023.233421.1201","DOIUrl":"https://doi.org/10.21608/jabps.2023.233421.1201","url":null,"abstract":"Hepatocellular carcinoma [HCC] is a brutally aggressive cancer that puts a tremendous amount of strain on both the medical systems and the drug regulatory organizations as well. It is believed that a crucial stage in the development of HCC is the epithelial-mesenchymal transition [EMT], which increases hepatocyte malignancy and is linked to invasion and metastasis. Resveratrol [RES] has been shown to reverse EMT in a number of cancer types. In order to further understand how RES influences EMT in HCC, we have chosen to concentrate on studying and summarizing the serine/threonine kinase [Akt]/glycogen synthesis kinase 3-beta [GSK3β]/Snail signaling pathway as one of the central pathways involved in activating EMT and tumorigenesis in this review.","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"7 s1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139167113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Younis, A. Gomaa, Alyaa Ibrahim, Samar Y. Desouky
{"title":"Pharmacognostical studies of the flower, leaf, root, and rhizome used for the identification and authentication of Agapanthus africanus (L.), cultivated in Egypt.","authors":"N. Younis, A. Gomaa, Alyaa Ibrahim, Samar Y. Desouky","doi":"10.21608/jabps.2023.232243.1197","DOIUrl":"https://doi.org/10.21608/jabps.2023.232243.1197","url":null,"abstract":"Agapanthus africanus [L.], is a rhizomatous evergreen plant with fleshy roots, linear leaves, and umbellate inflorescence. It is native to southern Africa and commonly named the Nile lily or African lily. Regarding how closely related their morphologies are, the members of the genus Agapanthus have proven challenging to divide into distinct species. Additionally, no documentation was detected for the phytochemical screening, macro and micromorphology of A. africanus up to date. This inspired us to describe the macro and micromorphology of the flower, leaf, root, and rhizome of A. africanus and evaluate its phytoconstituents. This study demonstrated that A. africanus is free from any trichomes and is rich with various forms of calcium oxalate crystals, both these characteristics help to define the plant under investigation. Concomitantly, the fibrous layer of the anther, the papillosed stigma, and the ellipsoid, non-spiny pollen grains, were recorded in the morphology of the flower in this study. The phytochemical screening investigated the presence of saponins, phenolics, and flavonoids as the major constituents of the underground parts of A. africanus . As expected, this resulted in a more precise tool for taxonomical identification and species delimitation of the genus","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"33 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139167036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sherif A. Gaballa, Youssef Naguib, Fatma Mady, Khaled Khaled
{"title":"Polyethylene glycol: Properties, applications, and challenges","authors":"Sherif A. Gaballa, Youssef Naguib, Fatma Mady, Khaled Khaled","doi":"10.21608/jabps.2023.241685.1205","DOIUrl":"https://doi.org/10.21608/jabps.2023.241685.1205","url":null,"abstract":"Polyethylene glycol (PEG) is a versatile polymer with overwhelming properties that enhance its abundant use in different applications. It is widely used in the food industry, various biomedical and pharmaceutical applications, and many daily used products such as cosmetics. In addition, PEGylation, the covalent binding of PEG molecules to nanocarriers, proteins, peptides, or drug molecules, has been designed as a brilliant approach to improve the pharmacokinetics and therapeutic efficacy of PEGylated therapeutics. The extensive application of PEGylation in the drug delivery field is reflected by the increasing number of commercially available PEGylated therapeutics approved through the last two decades and many others are under clinical trials for sooner approval. However, anti-PEG antibodies, both induced after the treatment with PEGylated therapeutics or naturally occurring in healthy individuals, were reported to negatively affect the pharmacokinetics and the therapeutic efficacy of the administered PEGylated therapeutics through the so-called accelerated blood clearance (ABC) phenomenon. Furthermore, hypersensitivity reactions (HSRs) have been reported in several cases following the administration of PEGylated therapeutics or other PEG-containing products. In addition, PEG nonbiodegradability, PEG degradation, and toxicity associated with polymerization reaction residues are remaining challenges. As a result, numerous polymers have been developed and investigated as potential alternatives for PEG in drug delivery and other medical and pharmaceutical applications.","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"24 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139167607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mostafa Mansour, Samar Abbas, Asma AboulMagd, Hamdy Abdel-Rahman, Mohamed Osman
{"title":"The significance of quinazoline derivatives as potential multi-target anti-cancer agents: review article","authors":"Mostafa Mansour, Samar Abbas, Asma AboulMagd, Hamdy Abdel-Rahman, Mohamed Osman","doi":"10.21608/jabps.2023.234736.1203","DOIUrl":"https://doi.org/10.21608/jabps.2023.234736.1203","url":null,"abstract":"In recent years, the use of quinazoline and its derivatives as structural scaffolds has shown significant promise in drug design. These compounds have shown significant biological efficacy in the treatment of a variety of diseases, including cancer. Quinazoline has shown a significant reduction in adverse effects and improved treatment effectiveness, making it a very attractive candidate for further investigation and advancement in therapeutic interventions. This review provides a focus on the use of small-molecule targeted therapy. The discussion briefly introduces the epidermal growth factor receptor tyrosine kinase (EGFR TK), its mutations, and the development of innovative molecules in this domain. Furthermore, the current review digs into the concept of multi-targeted anticancer agents, particularly on quinazoline-based compounds that can obstruct several targets. Notably, these targets include EGFR/VEGFR dual inhibitors, EGFR/HDAC dual inhibitors, and a variety of other EGFR-related targets.","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"4 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139166699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mahmoud EL-Badry, Ominia Mahmoud, Dina Fathalla, Gamal EL-Gendy
{"title":"Development and characterization of nanostructure lipid carrier for anti-hepatitis-C virus drug","authors":"Mahmoud EL-Badry, Ominia Mahmoud, Dina Fathalla, Gamal EL-Gendy","doi":"10.21608/jabps.2023.234602.1202","DOIUrl":"https://doi.org/10.21608/jabps.2023.234602.1202","url":null,"abstract":",","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"69 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139167851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Design, synthesis, and molecular docking of novel urea linked 1,2,3-triazole-benzenesulfonamide hybrid as potential carbonic anhydrase inhibitors","authors":"hamada hashem","doi":"10.21608/jabps.2023.243204.1206","DOIUrl":"https://doi.org/10.21608/jabps.2023.243204.1206","url":null,"abstract":".","PeriodicalId":14861,"journal":{"name":"Journal of advanced Biomedical and Pharmaceutical Sciences","volume":"6 32","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139166276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}